Alexion Pharmaceuticals, Inc.
Compositions comprising an anti-C5 antibody

Last updated:

Abstract:

The present application relates to methods and compositions employing an antibody that inhibits activation of the complement system and can be used to prevent or treat a pulmonary disease or condition.

Status:
Grant
Type:

Utility

Filling date:

9 Oct 2019

Issue date:

23 Feb 2021